Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review
MM Pathiyil, A Jena, AKV Raju… - The Lancet …, 2023 - thelancet.com
Inflammatory bowel disease (IBD) is now recognised as a global disease, with incidence
rapidly increasing in newly industrialised countries in South America, Asia, and Africa. Trials …
rapidly increasing in newly industrialised countries in South America, Asia, and Africa. Trials …
Liver transplantation for people of minoritised sexual and gender identities in the USA
TH Lee, N Duong, K Sutha, DA Simonetto… - The Lancet …, 2023 - thelancet.com
The number of people who report to be of minoritised sexual or gender identities in the USA,
including lesbian, gay, bisexual, transgender, queer, and other sexuality-diverse and gender …
including lesbian, gay, bisexual, transgender, queer, and other sexuality-diverse and gender …
[HTML][HTML] David Chiang, MD, PhD
D Chiang, V Chedid - mdedge9-beta.mdedge.com
Patient 1: 55-year-old cis-male, who identifies as gay, has ulcerative colitis that has been
refractory to multiple biologic therapies. His provider recommends a total proctocolectomy …
refractory to multiple biologic therapies. His provider recommends a total proctocolectomy …
[HTML][HTML] The New Gastroenterologist
S Umar - mdedge9-beta.mdedge.com
Medicine is transforming at a remarkable pace. It is therefore imperative for the future of the
field that physicians understand innovation and collaborate with industry partners …
field that physicians understand innovation and collaborate with industry partners …